当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:124.84亿  总市值:148.40亿
流通股本:6.30亿   总股本:7.49亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润0.70亿元,每股收益0.10元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益807918.83万元,未分配利润209496.91万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产939615.26万元,负债131696.44万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入2,018,333,771.811,335,156,050.4849,356,544.11324,809,103.67
营业总成本1,763,748,341.311,227,734,251.03753,062,458.9293,294,646.96
营业利润104,347,309.12-69,661,013.72-177,154,741.3-293,008,274.73
利润总额104,039,073.62-69,892,269.79-177,351,107.31-293,130,015.64
净利润69,755,063.9-74,244,009.94-172,238,316.14-273,363,603.07
其他综合收益-51,041,084.41-4,859,185.753,024,917.86863,793.54
综合收益总额18,713,979.49-79,103,195.69-169,213,398.28-272,499,809.53
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计5,031,197,927.385,334,112,028.965,492,884,034.546,971,164,178.58
非流动资产合计4,364,954,683.074,191,072,779.024,168,389,654.142,762,090,308.72
资产总计9,396,152,610.459,525,184,807.989,661,273,688.689,733,254,487.3
流动负债合计1,110,568,596.281,298,706,870.561,518,194,812.491,502,563,540.44
非流动负债合计206,395,760.21235,643,339.19227,837,447.75236,962,783.63
负债合计1,316,964,356.491,534,350,209.751,746,032,260.241,739,526,324.07
归属于母公司股东权益合计8,078,818,586.728,002,435,682.27,916,012,413.27,993,144,600.58
股东权益合计8,079,188,253.967,990,834,598.237,915,241,428.447,993,728,163.23
负债和股东权益合计9,396,152,610.459,525,184,807.989,661,273,688.689,733,254,487.3
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计1,811,387,046.151,367,691,390.73919,139,371.69492,589,961.1
经营活动现金流出小计1,472,458,327.751,175,365,681.39761,422,728.38372,636,441.79
经营活动产生的现金流量净额338,928,718.4192,325,709.34157,716,643.31119,953,519.31
投资活动现金流入小计3,365,501,966.772,508,098,115.211,914,486,106.33111,453,520.72
投资活动现金流出小计5,328,525,952.313,458,148,881.922,660,158,066.46179,015,819.37
投资活动产生的现金流量净额-1,963,023,985.54-950,050,766.71-745,671,960.13-67,562,298.65
筹资活动现金流入小计----
筹资活动现金流出小计265,627,486.97248,828,091.97107,250,255.9937,928,364.49
筹资活动产生的现金流量净额-265,627,486.97-248,828,091.97-107,250,255.99-37,928,364.49
汇率变动对现金及现金等价物的影响1,278,854.73-6,969,366.76-246,310.23-2,795,727.79
现金及现金等价物净增加额-1,888,443,899.38-1,013,522,516.1-695,451,883.0411,667,128.38
期末现金及现金等价物余额965,203,128.591,840,124,511.872,158,195,144.932,865,314,156.35
最新报告期:2025-04-01
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
华西证券崔文亮,徐顺利0.500.480.502025-04-01
中金公司张琎,吴婉桦0.520.54--2025-04-01
申万宏源王道0.480.510.592025-03-31
海通证券周航,余文心,贺文斌0.090.490.622025-03-07
TOP↑